Aparito and Pulse Infoframe Announce Strategic Partnership
Aparito, a company transforming healthcare by unlocking real-world patient data through mobile apps and wearable devices, and Pulse Infoframe, a leading cloud-based healthcare data insights company delivering a holistic solution to foster collaboration and answer complex research, statistical and economical questions have announced a strategic partnership in rare disease.
Mon Mar 16 2020 03:30:00 GMT+0000 (Coordinated Universal Time)
Daniel Lewi has joined Aparito as the new Business Development Manager and brings with him extensive experience in the rare disease space. As the founder of the rare disease charity The Cure & Action for Tay-Sachs (CATS) Foundation, he is fully aware of the challenges that many families face when taking part in clinical trials whilst also juggling their day to day life.
Wed Jan 15 2020 16:30:00 GMT+0000 (Coordinated Universal Time)
Precision management (PM) of Complex Epilepsy in South African Children: mHealth follow up completed.
After two year of active recruitment by Principal Investigator Dr Karen Fieggen, University of Cape Town (UCT) and Clinical Co-Investigator Prof Jo Wilmshurst, of Red CrossChildren’s War Memorial Hospital in Cape Town, South Africa we are delighted to announce that this study using Aparito’s Atom5 platform is now completed.
Tue Dec 03 2019 12:10:00 GMT+0000 (Coordinated Universal Time)
What is Sanfilippo Syndrome? Imagine Alzheimer's, but for children.
These are the words from the Cure Sanfilippo Foundation. An advocacy group working to cure the disease. Sanfilippo syndrome, also known as mucopolysaccharidosis type III (MPS III), is a rare autosomal recessive lysosomal storage disease that primarily affects the brain and spinal cord.
Sat Nov 16 2019 05:00:00 GMT+0000 (Coordinated Universal Time)
Aparito 5th Birthday Conference and Celebration: Conference Summary
To mark our fifth year of operation we invited patients, health care professionals and researchers representing our therapeutic focus areas to share their experiences of working with the Aparito platform. We chose examples that would highlight Aparito’s patient focus, with stories of collaboration to deliver monitoring outside of the hospital (often remotely) using our ePRO modules.
Our Precision Medicine study in partnership with Red Cross Children’s War Memorial and University of Cape Town, South Africa is progressing well. Recruitment is now almost complete, and the majority of participants are engaging well with using the technology. Some challenges have been encountered, which is not unexpected when deploying innovative technology and supporting a cohort of families with limited resources whose children have multiple neurological disabilities, and whose care takes up a lot of time. This experience is invaluable, and as planned in this pilot study provides insight into the realities for future E-health initiatives for routine care and research in South Africa.
Fri Mar 08 2019 09:30:00 GMT+0000 (Coordinated Universal Time)
Newton funded epilepsy study starts enrolling patients
The Red Cross War Memorial Children’s Hospital, Cape Town South Africa in partnership with Aparito, a Welsh based digital health company recruited their first patient in June following the successful deployment of Atom 5 – a software platform to enable next generation remote patient monitoring.
Award- winning digital health company launches latest version of flagship software
Aparito, the leading provider of remote patient monitoring and digital health technology supporting rare diseases, announces today the launch of its very latest build of its core product - Atom 5, Helium edition.
Fri Jun 15 2018 08:00:00 GMT+0000 (Coordinated Universal Time)
Welsh health data company Aparito were represented at the UK wide AXA 2018 Health Tech & You awards ceremony held on the 9th May 2018 at the headquarters of the Royal College of General Practitioners in London. The company who were established in 2014 were joint winners of the Health Tech & You award for early diagnosis of dementia. Dr Elin Haf Davies, Aparito’s founder and Chief Executive Officer who hails from Bala but now lives in London, collected the award for the company’s proposal using a machine learning platform to monitor changes in sleep, activity, voice, ADL and memory collectively.
Thu May 31 2018 09:00:00 GMT+0000 (Coordinated Universal Time)
Press Release: Precision Management (PM) of Epilepsy in South African Children
Welsh based digital health company Aparito, today announced that they have been awarded funding by the Newton Fund to deploy their technology in South Africa. The Newton Fund builds research and innovation partnerships with 18 partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total UK Government investment of £735 million up until 2021, with matched resources from the partner countries.
Thu Feb 15 2018 09:00:00 GMT+0000 (Coordinated Universal Time)